China stocks reversed earlier gains to end lower on Monday, weighed down by losses in healthcare shares as a vaccine scandal that has sparked public fury drove investors to extend a recent selloff.
The blue-chip CSI300 index fell 0.2 percent to 3,515.08, while the Shanghai Composite Index slipped 0.1 percent to 2,869.05.
Bucking the broad weakness, infrastructure stocks climbed as investors expect such companies to benefit from Beijing’s planned infrastructure boost.
China plans to put more money into infrastructure projects and ease borrowing curbs on local governments to help soften the blow to the economy from the Sino-U.S. trade war, policy sources told Reuters.
Healthcare firms tumbled, with an index tracking major healthcare stocks ending down 2.9 percent, as a vaccine scandal continued to dampen risk appetite for the sector.
Source : Reuters